Lv6
1817 积分 2024-01-19 加入
FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspective
15天前
已完结
Role of Data in Development and Application of Quantitative Systems Pharmacology Models
15天前
已完结
Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood
15天前
已完结
No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost
15天前
已完结
Recommendations for a standardized publication protocol for a QSP model
15天前
已完结
Prediction of pharmacokinetics and CNS effects of fentanyl and alfentanil in mice, rats and humans using cross-species PBPK-PD model and in vitro PK/PD parameters
1个月前
已完结
Development of a generic physiologically based pharmacokinetic model to predict clinical pharmacokinetics and assess drug-drug interaction risks for vcMMAE-based antibody-drug conjugates
2个月前
已完结
Development of a generic physiologically based pharmacokinetic model to predict clinical pharmacokinetics and assess drug-drug interaction risks for valine-citrulline-monomethyl auristatin E-based antibody-drug conjugates
2个月前
已关闭
Astragaloside IV Exhibited Antidiabetic Effects by Improving Glucose Metabolism, Repairing Damaged Gut Barrier and Regulating Intestinal Microbiota
3个月前
已完结
Development and application of a CNS PBPK model that integrates CSF dynamics to optimize dosing regimens of antibacterial agents in pediatric patients with meningitis
3个月前
已完结
皖公网安备34019202002308
